X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB NOVARTIS UNICHEM LAB/
NOVARTIS
 
P/E (TTM) x 22.4 347.8 6.4% View Chart
P/BV x 2.4 17.1 13.8% View Chart
Dividend Yield % 0.8 1.7 47.8%  

Financials

 UNICHEM LAB   NOVARTIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
NOVARTIS
Mar-16
UNICHEM LAB/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs334982 34.0%   
Low Rs174556 31.3%   
Sales per share (Unadj.) Rs146.9252.9 58.1%  
Earnings per share (Unadj.) Rs11.962.1 19.1%  
Cash flow per share (Unadj.) Rs16.263.3 25.6%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.81.3 60.6%  
Book value per share (Unadj.) Rs105.1363.6 28.9%  
Shares outstanding (eoy) m90.8431.96 284.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.73.0 56.9%   
Avg P/E ratio x21.412.4 172.6%  
P/CF ratio (eoy) x15.712.2 129.1%  
Price / Book Value ratio x2.42.1 114.2%  
Dividend payout %16.816.1 104.5%   
Avg Mkt Cap Rs m23,07324,580 93.9%   
No. of employees `0005.70.8 754.4%   
Total wages/salary Rs m2,5581,801 142.0%   
Avg. sales/employee Rs Th2,352.510,748.9 21.9%   
Avg. wages/employee Rs Th450.92,395.2 18.8%   
Avg. net profit/employee Rs Th190.42,641.1 7.2%   
INCOME DATA
Net Sales Rs m13,3468,083 165.1%  
Other income Rs m192829 23.1%   
Total revenues Rs m13,5388,913 151.9%   
Gross profit Rs m1,639234 699.8%  
Depreciation Rs m39037 1,062.7%   
Interest Rs m292 1,600.0%   
Profit before tax Rs m1,4121,025 137.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-417 -22.2%   
Extraordinary Inc (Exp) Rs m-351,696 -2.1%   
Tax Rs m293752 38.9%   
Profit after tax Rs m1,0801,986 54.4%  
Gross profit margin %12.32.9 423.9%  
Effective tax rate %20.773.4 28.3%   
Net profit margin %8.124.6 32.9%  
BALANCE SHEET DATA
Current assets Rs m5,97912,678 47.2%   
Current liabilities Rs m2,4322,433 100.0%   
Net working cap to sales %26.6126.7 21.0%  
Current ratio x2.55.2 47.2%  
Inventory Days Days6333 192.9%  
Debtors Days Days6022 268.5%  
Net fixed assets Rs m6,40369 9,252.3%   
Share capital Rs m182160 113.7%   
"Free" reserves Rs m9,29311,460 81.1%   
Net worth Rs m9,54811,621 82.2%   
Long term debt Rs m2300-   
Total assets Rs m12,84314,400 89.2%  
Interest coverage x50.0570.5 8.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.6 185.1%   
Return on assets %8.613.8 62.6%  
Return on equity %11.317.1 66.2%  
Return on capital %14.323.6 60.8%  
Exports to sales %29.20.7 3,923.5%   
Imports to sales %6.318.6 34.1%   
Exports (fob) Rs m3,90060 6,477.7%   
Imports (cif) Rs m8471,503 56.3%   
Fx inflow Rs m4,356186 2,338.4%   
Fx outflow Rs m1,1621,821 63.8%   
Net fx Rs m3,194-1,635 -195.4%   
CASH FLOW
From Operations Rs m1,1192,531 44.2%  
From Investments Rs m-853-8,270 10.3%  
From Financial Activity Rs m-334-386 86.6%  
Net Cashflow Rs m-68-6,125 1.1%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 2.0 755.0%  
FIIs % 3.0 1.6 187.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.5 147.4%  
Shareholders   20,176 41,647 48.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 18, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - GSK PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS